4.6 Article

Role of Dopamine 2 Receptor in Impaired Drug-Cue Extinction in Adolescent Rats

Journal

CEREBRAL CORTEX
Volume 26, Issue 6, Pages 2895-2904

Publisher

OXFORD UNIV PRESS INC
DOI: 10.1093/cercor/bhw051

Keywords

adolescence; aripiprazole; dopamine; extinction; infralimbic cortex

Categories

Funding

  1. National Health and Medical Research Council (NHMRC) of Australia [APP1063140]
  2. Australian Postgraduate Award
  3. Baker Foundation Fellowship
  4. NHMRC Peter Doherty Fellowship
  5. NHMRC Principal Research Fellowship [1020737]
  6. Australian Research Council Discovery Early Career Research Award Fellowship [DE120100110]
  7. Australian Research Council [DE120100110] Funding Source: Australian Research Council

Ask authors/readers for more resources

Adolescent drug users display resistance to treatment such as cue exposure therapy (CET), as well as increased liability to relapse. The basis of CET is extinction learning, which involves dopamine signaling in the medial prefrontal cortex (mPFC). This system undergoes dramatic alterations during adolescence. Therefore, we investigated extinction of a cocaine-associated cue in adolescent and adult rats. While cocaine self-administration and lever-alone extinction were not different between the two ages, we observed that cue extinction reduced cue-induced reinstatement in adult but not adolescent rats. Infusion of the selective dopamine 2 receptor (D2R)-like agonist quinpirole into the infralimbic cortex (IL) of the mPFC prior to cue extinction significantly reduced cue-induced reinstatement in adolescents. This effect was replicated by acute systemic treatment with the atypical antipsychotic aripiprazole (Abilify), a partial D2R-like agonist. These data suggest that adolescents may be more susceptible to relapse due to a deficit in cue extinction learning, and highlight the significance of D2R signaling in the IL for cue extinction during adolescence. These findings inspire new tactics for improving adolescent CET, with aripiprazole representing an exciting potential pharmacological adjunct for behavioral therapy.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available